Cargando…
Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers
PURPOSE: The recent repurposing of ketamine as treatment for pain and depression has increased the need for accurate population pharmacokinetic (PK) models to inform the design of new clinical trials. Therefore, the objectives of this study were to externally validate available PK models on (S)-(nor...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275530/ https://www.ncbi.nlm.nih.gov/pubmed/33575848 http://dx.doi.org/10.1007/s00228-021-03104-1 |
_version_ | 1783721734707347456 |
---|---|
author | Otto, M. E. Bergmann, K. R. Jacobs, G. van Esdonk, Michiel J. |
author_facet | Otto, M. E. Bergmann, K. R. Jacobs, G. van Esdonk, Michiel J. |
author_sort | Otto, M. E. |
collection | PubMed |
description | PURPOSE: The recent repurposing of ketamine as treatment for pain and depression has increased the need for accurate population pharmacokinetic (PK) models to inform the design of new clinical trials. Therefore, the objectives of this study were to externally validate available PK models on (S)-(nor)ketamine concentrations with in-house data and to improve the best performing model when necessary. METHODS: Based on predefined criteria, five models were selected from literature. Data of two previously performed clinical trials on (S)-ketamine administration in healthy volunteers were available for validation. The predictive performances of the selected models were compared through visual predictive checks (VPCs) and calculation of the (root) mean (square) prediction errors (ME and RMSE). The available data was used to adapt the best performing model through alterations to the model structure and re-estimation of inter-individual variability (IIV). RESULTS: The model developed by Fanta et al. (Eur J Clin Pharmacol 71:441–447, 2015) performed best at predicting the (S)-ketamine concentration over time, but failed to capture the (S)-norketamine C(max) correctly. Other models with similar population demographics and study designs had estimated relatively small distribution volumes of (S)-ketamine and thus overpredicted concentrations after start of infusion, most likely due to the influence of circulatory dynamics and sampling methodology. Model predictions were improved through a reduction in complexity of the (S)-(nor)ketamine model and re-estimation of IIV. CONCLUSION: The modified model resulted in accurate predictions of both (S)-ketamine and (S)-norketamine and thereby provides a solid foundation for future simulation studies of (S)-(nor)ketamine PK in healthy volunteers after (S)-ketamine infusion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00228-021-03104-1. |
format | Online Article Text |
id | pubmed-8275530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82755302021-07-20 Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers Otto, M. E. Bergmann, K. R. Jacobs, G. van Esdonk, Michiel J. Eur J Clin Pharmacol Pharmacokinetics and Disposition PURPOSE: The recent repurposing of ketamine as treatment for pain and depression has increased the need for accurate population pharmacokinetic (PK) models to inform the design of new clinical trials. Therefore, the objectives of this study were to externally validate available PK models on (S)-(nor)ketamine concentrations with in-house data and to improve the best performing model when necessary. METHODS: Based on predefined criteria, five models were selected from literature. Data of two previously performed clinical trials on (S)-ketamine administration in healthy volunteers were available for validation. The predictive performances of the selected models were compared through visual predictive checks (VPCs) and calculation of the (root) mean (square) prediction errors (ME and RMSE). The available data was used to adapt the best performing model through alterations to the model structure and re-estimation of inter-individual variability (IIV). RESULTS: The model developed by Fanta et al. (Eur J Clin Pharmacol 71:441–447, 2015) performed best at predicting the (S)-ketamine concentration over time, but failed to capture the (S)-norketamine C(max) correctly. Other models with similar population demographics and study designs had estimated relatively small distribution volumes of (S)-ketamine and thus overpredicted concentrations after start of infusion, most likely due to the influence of circulatory dynamics and sampling methodology. Model predictions were improved through a reduction in complexity of the (S)-(nor)ketamine model and re-estimation of IIV. CONCLUSION: The modified model resulted in accurate predictions of both (S)-ketamine and (S)-norketamine and thereby provides a solid foundation for future simulation studies of (S)-(nor)ketamine PK in healthy volunteers after (S)-ketamine infusion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00228-021-03104-1. Springer Berlin Heidelberg 2021-02-11 2021 /pmc/articles/PMC8275530/ /pubmed/33575848 http://dx.doi.org/10.1007/s00228-021-03104-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Pharmacokinetics and Disposition Otto, M. E. Bergmann, K. R. Jacobs, G. van Esdonk, Michiel J. Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title | Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title_full | Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title_fullStr | Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title_full_unstemmed | Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title_short | Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers |
title_sort | predictive performance of parent-metabolite population pharmacokinetic models of (s)-ketamine in healthy volunteers |
topic | Pharmacokinetics and Disposition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275530/ https://www.ncbi.nlm.nih.gov/pubmed/33575848 http://dx.doi.org/10.1007/s00228-021-03104-1 |
work_keys_str_mv | AT ottome predictiveperformanceofparentmetabolitepopulationpharmacokineticmodelsofsketamineinhealthyvolunteers AT bergmannkr predictiveperformanceofparentmetabolitepopulationpharmacokineticmodelsofsketamineinhealthyvolunteers AT jacobsg predictiveperformanceofparentmetabolitepopulationpharmacokineticmodelsofsketamineinhealthyvolunteers AT vanesdonkmichielj predictiveperformanceofparentmetabolitepopulationpharmacokineticmodelsofsketamineinhealthyvolunteers |